132 related articles for article (PubMed ID: 6314889)
1. Penetration of sulbactam and ampicillin into peritoneal fluid.
Wise R; Donovan IA; Andrews JM; Drumm J; Bennett S
Antimicrob Agents Chemother; 1983 Aug; 24(2):290-2. PubMed ID: 6314889
[TBL] [Abstract][Full Text] [Related]
2. Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.
Houang ET; Colley N; Chapman M
Antimicrob Agents Chemother; 1985 Jul; 28(1):165-6. PubMed ID: 2994556
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.
Brown RM; Wise R; Andrews JM; Hancox J
Antimicrob Agents Chemother; 1982 Apr; 21(4):565-7. PubMed ID: 6282211
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of sulbactam/ampicillin in humans: a review.
Foulds G
Rev Infect Dis; 1986; 8 Suppl 5():S503-11. PubMed ID: 3025997
[TBL] [Abstract][Full Text] [Related]
5. Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
Pfaller M; Barry A; Fuchs P; Gerlach E; Hardy D; McLaughlin J
Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):200-5. PubMed ID: 8389705
[TBL] [Abstract][Full Text] [Related]
6. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
Campoli-Richards DM; Brogden RN
Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
[TBL] [Abstract][Full Text] [Related]
7. Biliary pharmacokinetics of sulbactam plus ampicillin in humans.
Morris DL; Ubhi CS; Robertson CS; Brammer KW
Rev Infect Dis; 1986; 8 Suppl 5():S589-92. PubMed ID: 3026008
[TBL] [Abstract][Full Text] [Related]
8. Sulbactam: biochemical factors involved in its synergy with ampicillin.
Labia R; Morand A; Lelievre V; Mattioni D; Kazmierczak A
Rev Infect Dis; 1986; 8 Suppl 5():S496-502. PubMed ID: 3025996
[TBL] [Abstract][Full Text] [Related]
9. Effects of ampicillin plus sulbactam on bowel flora in patients undergoing colorectal surgery.
Kager L; Liljeqvist L; Malmborg AS; Nord CE; Pieper R
Antimicrob Agents Chemother; 1982 Aug; 22(2):208-12. PubMed ID: 6100422
[TBL] [Abstract][Full Text] [Related]
10. Concentration of sulbactam and ampicillin in serum and the myometrium.
Schwiersch U; Lang N; Wildfeuer DA
Drugs; 1986; 31 Suppl 2():26-8. PubMed ID: 3013570
[TBL] [Abstract][Full Text] [Related]
11. The parenteral kinetics of ampicillin/sulbactam in man.
Foulds G; Knirsch AK; Stankewich JP; Weidler DR
Int J Clin Pharmacol Res; 1985; 5(2):79-86. PubMed ID: 2991150
[TBL] [Abstract][Full Text] [Related]
12. Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.
Aronoff SC; Jacobs MR; Johenning S; Yamabe S
Antimicrob Agents Chemother; 1984 Oct; 26(4):580-2. PubMed ID: 6097169
[TBL] [Abstract][Full Text] [Related]
13. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.
Wexler HM; Harris B; Carter WT; Finegold SM
Antimicrob Agents Chemother; 1985 May; 27(5):876-8. PubMed ID: 2990330
[TBL] [Abstract][Full Text] [Related]
14. Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis.
Sorg TB; Cynamon MH
J Antimicrob Chemother; 1987 Jan; 19(1):59-64. PubMed ID: 3030999
[TBL] [Abstract][Full Text] [Related]
15. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
Jacobs MR; Aronoff SC; Johenning S; Shlaes DM; Yamabe S
Antimicrob Agents Chemother; 1986 Jun; 29(6):980-5. PubMed ID: 3015017
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of ampicillin alone and in combination with sulbactam correlated with beta-lactamase production.
Chao HP; Ho SW; Luh KT; Hsieh WC
Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):241-7. PubMed ID: 3037003
[No Abstract] [Full Text] [Related]
17. In-vitro evaluation of sulbactam, a penicillanic acid sulphone with beta-lactamase inhibitory properties.
Greenwood D; Eley A
J Antimicrob Chemother; 1982 Aug; 10(2):117-23. PubMed ID: 6288651
[No Abstract] [Full Text] [Related]
18. In vitro activity of YTR 830.
Jacobs MR; Aronoff SC; Appelbaum PC; Yamabe S
J Chemother; 1989 Jun; 1(3):151-4. PubMed ID: 2552029
[TBL] [Abstract][Full Text] [Related]
19. In vitro bactericidal activity of sulbactam plus ampicillin against methicillin-resistant Staphylococcus aureus.
Kazmierczak A; Duez JM; Pechinot A; Nordmann P; Labia R
Rev Infect Dis; 1986; 8 Suppl 5():S549-54. PubMed ID: 3026003
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of sultamicillin in mice, rats, and dogs.
English AR; Girard D; Haskell SL
Antimicrob Agents Chemother; 1984 May; 25(5):599-602. PubMed ID: 6329091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
